{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:12:26Z","timestamp":1791893546660,"version":"4.3.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Densitometry"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.jocd.2012.12.001","type":"journal-article","created":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T02:03:12Z","timestamp":1359597792000},"page":"33-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":148,"title":["Normocalcemic Primary Hyperparathyroidism"],"prefix":"10.1016","volume":"16","author":[{"given":"Natalie E.","family":"Cusano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shonni J.","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Bilezikian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocd.2012.12.001_bib1","series-title":"Primer on Metabolic Bone Diseases and Disorders of Mineral Metabolism","article-title":"Primary hyperparathyroidism","author":"Bilezikian","year":"2009"},{"key":"10.1016\/j.jocd.2012.12.001_bib2","series-title":"The Parathyroids: Basic and Clinical Concepts","author":"Bilezikian","year":"2001"},{"key":"10.1016\/j.jocd.2012.12.001_bib3","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199910213411701","article-title":"A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery","volume":"341","author":"Silverberg","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocd.2012.12.001_bib4","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1210\/jc.2007-1215","article-title":"The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years","volume":"93","author":"Rubin","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2012.12.001_bib5","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1210\/jc.2002-021404","article-title":"Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone","volume":"88","author":"Maruani","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2012.12.001_bib6","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1210\/jc.2003-031014","article-title":"\u201cIncipient\u201d primary hyperparathyroidism: a \u201cforme fruste\u201d of an old disease","volume":"88","author":"Silverberg","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2012.12.001_bib7","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jcem-67-6-1294","article-title":"Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for biphasic disease course","volume":"67","author":"Rao","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2012.12.001_bib8","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1590\/S0004-27302010000200004","article-title":"Normocalcemic primary hyperparathyroidism","volume":"54","author":"Bilezikian","year":"2010","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.jocd.2012.12.001_bib9","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1210\/jc.2008-1763","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop","volume":"94","author":"Bilezikian","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2012.12.001_bib10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.7326\/0003-4819-118-5-199303010-00003","article-title":"Estrogen protection against bone resorbing effects of parathyroid hormone infusion. Assessment by use of biochemical markers","volume":"118","author":"Cosman","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jocd.2012.12.001_bib11","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0140-6736(72)90173-0","article-title":"Treatment with with oestrogens of primary hyperparathyroidism in post-menopausal women","volume":"1","author":"Gallagher","year":"1972","journal-title":"Lancet"},{"key":"10.1016\/j.jocd.2012.12.001_bib12","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1056\/NEJM198606053142304","article-title":"Ethinyl estradiol and norethindrone in the treatment of primary hyperparathyroidism in postmenopausal women","volume":"314","author":"Selby","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocd.2012.12.001_bib13","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/0002-9343(69)90222-8","article-title":"Normocalcemic primary hyperparathyroidism","volume":"47","author":"Wills","year":"1969","journal-title":"Am J Med"},{"key":"10.1016\/j.jocd.2012.12.001_bib14","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.surg.2004.06.052","article-title":"Normocalcemic hyperparathyroidism in patients with osteoporosis","volume":"136","author":"Monchik","year":"2004","journal-title":"Surgery"},{"key":"10.1016\/j.jocd.2012.12.001_bib15","series-title":"Dietary Reference Intakes","article-title":"Dietary reference intakes for calcium and vitamin D","year":"2011"},{"key":"10.1016\/j.jocd.2012.12.001_bib16","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0272-6386(97)90330-9","article-title":"The importance of dietary calcium and phosphorous in the secondary hyperparathyroidism of patients with early renal failure","volume":"29","author":"Martinez","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jocd.2012.12.001_bib17","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0272-6386(03)00905-3","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jocd.2012.12.001_bib18","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","volume":"76","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.jocd.2012.12.001_bib19","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1210\/jc.2011-3072","article-title":"Effect of renal function on skeletal health in primary hyperparathyroidism","volume":"97","author":"Walker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2012.12.001_bib20","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1001\/jama.1969.03160330043008","article-title":"Hyperparathyroidism coexisting with hypertension and prolonged thiazide administration","volume":"210","author":"Paloyan","year":"1969","journal-title":"JAMA"},{"key":"10.1016\/j.jocd.2012.12.001_bib21","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1210\/jcem-68-3-654","article-title":"Lithium treatment increases intact and midregion parathyroid hormone and parathyroid volume","volume":"68","author":"Mallette","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2012.12.001_bib22","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1172\/JCI107156","article-title":"Evidence for\u00a0secondary hyperparathyroidism in idiopathic hypercalciuria","volume":"52","author":"Coe","year":"1973","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jocd.2012.12.001_bib23","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/BF03346429","article-title":"Role of calcium malabsorption in the development of secondary hyperparathyroidism after biliopancreatic diversion","volume":"31","author":"Balsa","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.jocd.2012.12.001_bib24","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1359\/jbmr.1999.14.4.652","article-title":"Bone loss in\u00a0celiac disease is related to secondary hyperparathyroidism","volume":"14","author":"Selby","year":"1999","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.jocd.2012.12.001_bib25","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1210\/jc.2006-2802","article-title":"Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype","volume":"92","author":"Lowe","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2012.12.001_bib26","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.amjmed.2004.06.037","article-title":"Characterization of normocalcemic primary hyperparathyroidism","volume":"117","author":"Tordjman","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.jocd.2012.12.001_bib27","doi-asserted-by":"crossref","first-page":"128352","DOI":"10.1155\/2012\/128352","article-title":"Normocalcemic versus hypercalcemic primary hyperparathyroidism: more stone than bone?","volume":"2012","author":"Amaral","year":"2012","journal-title":"J Osteoporos"},{"key":"10.1016\/j.jocd.2012.12.001_bib28","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s12020-012-9627-x","article-title":"Investigation of insulin resistance in patients with normocalcemic primary hyperparathyroidism","volume":"42","author":"Cakir","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/j.jocd.2012.12.001_bib29","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00268-012-1438-y","article-title":"Surgical management of normocalcemic primary hyperparathyroidism","volume":"36","author":"Wade","year":"2012","journal-title":"World J Surg"},{"key":"10.1016\/j.jocd.2012.12.001_bib30","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1210\/jc.2005-2102","article-title":"Effect of primary hyperparathyroidism on volumetric bone mineral density and bone geometry assessed by peripheral quantitative computed tomography in postmenopausal women","volume":"91","author":"Charopoulos","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2012.12.001_bib31","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/s12020-012-9694-z","article-title":"Normocalcemic primary hyperparathyroidism: one-year follow-up in one hundred postmenopausal women","volume":"42","author":"Garcia-Martin","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/j.jocd.2012.12.001_bib32","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0039-6060(97)90357-3","article-title":"Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women","volume":"121","author":"Lundgren","year":"1997","journal-title":"Surgery"},{"key":"10.1016\/j.jocd.2012.12.001_bib33","unstructured":"Misra B, McMahon DJ, Silverberg SJ, Bilezikian JP. New data on the impact of renal function on the relationship between 25-hydroxyvitamin D and parathyroid hormone. Proc 30th Annual Meeting of the American Society of Bone and Mineral Research, Montreal, Canada, p1031;\u00a02008."},{"key":"10.1016\/j.jocd.2012.12.001_bib34","unstructured":"Berger C, Langsetmo L, Hanley D, et\u00a0al. Relative prevalence of normocalcemic and hypercalcemic hyperparathryoidism in a community-dwelling cohort. Proc 33rd Annual Meeting of the American Society of Bone and Mineral Research, San Diego, California, pSU0173;\u00a02011."}],"container-title":["Journal of Clinical Densitometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695012002430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695012002430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:37:29Z","timestamp":1761082649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094695012002430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S1094695012002430"],"URL":"https:\/\/doi.org\/10.1016\/j.jocd.2012.12.001","relation":{},"ISSN":["1094-6950"],"issn-type":[{"value":"1094-6950","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Normocalcemic Primary Hyperparathyroidism","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Densitometry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocd.2012.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The International Society for Clinical Densitometry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}